Company intelligence / Profile preview

Vivos BioTechnologies

Littleton, Colorado, United Statesvivos.com ↗

Ownership: Private
Employees: ~109
Development stage: Commercial

Overview

The company has developed and commercialized FDA-cleared oral medical devices for treating mild, moderate, and severe obstructive sleep apnea in adults. Their main product suite—The Vivos Method—offers a non-surgical, non-invasive alternative to CPAP or surgery. Over 40,000 patients have been treated worldwide with positive clinical outcomes reported.

Therapeutic areas: Pulmonology
Modalities: DeviceOral appliance
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Vivos BioTechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vivos BioTechnologies.

Explore the full profile